SensoDetect AB Logo

SensoDetect AB

Develops AI decision-support solutions for mental illness diagnostics.

SDET | SPGR

Overview

Corporate Details

ISIN(s):
SE0003037456 (+1 more)
LEI:
549300BPUMGJZ3N7QM92
Country:
Sweden
Address:
Arenagatan 31, 215 32 Malmö

Description

SensoDetect AB is a neurodiagnostics MedTech and artificial intelligence (AI) company that develops objective decision-support solutions for mental illness. Based on over 30 years of research in clinical psychoacoustics, the company's core technology analyzes Auditory Brainstem Response (ABR) signals to provide quantitative data on the brain's reaction to sound. This system is designed to assist healthcare professionals in the assessment of psychiatric disorders such as schizophrenia, ADHD, and autism, aiming to improve diagnostic accuracy and patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SensoDetect AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SensoDetect AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SensoDetect AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-22 Johan Granath Other Other 1,223,955 183,593.25 SEK
2025-01-21 per-anders hedin Other Other 3,214,285 482,142.75 SEK
2025-01-21 Johan Möllerström Other Other 2,170,535 325,580.25 SEK
2025-01-21 Johan Möllerström Other Other 1,836,610 275,491.50 SEK
2025-01-21 Johan Möllerström Other Other 714,285 107,142.75 SEK
2025-01-21 Wendi Ma Other Other 66,392 9,958.80 SEK
2025-01-21 Per-Anders Hedin Other Other 43,050 6,457.50 SEK
2025-01-21 Wendi Ma Other Other 66,392 N/A

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.